Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Other hematologic neoplasm 1NET 1Lymphoid 1Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

Everolimus 2lutetium Lu 177 dotatate 1Somatostatin 1Sirolimus 1Positron Emission Tomography Computed Tomography 1Oxaliplatin 1Leucovorin 1Injections 1Fluorouracil 1Bevacizumab 1Axitinib 1Al18F-NOTA-octreotide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Positron Emission Tomography Computed Tomography × NET × Clear all
NCT04552847 2022-02-17

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Universitaire Ziekenhuizen KU Leuven

Phase 2/3 Completed
85 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡